Research progress on cholesterol metabolism and tumor therapy
Open Access
- 30 April 2025
- journal article
- review article
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-23
Abstract
Cholesterol and its metabolic derivatives have important biological functions and are crucial in tumor initiation, progression, and treatment. Cholesterol maintains the physical properties of cellular membranes and is pivotal in cell signal transduction. Cholesterol metabolism includes both de novo synthesis and uptake from extracellular sources such as low-density lipoprotein (LDL) and high-density lipoprotein (HDL). This review explores both aspects to provide a comprehensive understanding of their roles in cancer. Cholesterol metabolism is involved in bile acid production and steroid hormone biosynthesis and is closely linked to the reprogramming of endogenous and exogenous cellular signals within the tumor microenvironment. These signals are intricately associated with key biological processes such as tumor cell proliferation, survival, invasion, and metastasis. Evidence suggests that regulating cholesterol metabolism may offer therapeutic benefits by inhibiting tumor growth, remodeling the immune microenvironment, and enhancing antitumor immune responses. This review summarizes the role of cholesterol metabolism in tumor biology and discusses the application of statins and other cholesterol metabolism inhibitors in cancer therapy, aiming to provide novel insights for the development of antitumor drugs targeting cholesterol metabolism and for advances in cancer diagnosis and treatment.Keywords
Funding Information
- China Postdoctoral Science Foundation (2024M762107)
- Key Discipline Construction Project of Shanghai's Three Year Action Plan for Strengthening the Construction of Public Health System (GWVI-11.1-24)
- Shanghai 2022 ‘Science and Technology Innovation Action Plan’ Medical Innovation Research Special Project (22Y11922200)
- National Natural Science Foundation of China (82374002)
- Program of Shanghai Academic/Technology Research Leader (22XD1423000)
This publication has 116 references indexed in Scilit:
- LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL ReceptorScience, 2009
- Ezetimibe Is an Inhibitor of Tumor AngiogenesisThe American Journal of Pathology, 2009
- Mitochondrial Cholesterol Contributes to Chemotherapy Resistance in Hepatocellular CarcinomaCancer Research, 2008
- Apolipoprotein E Expression in Anaplastic Thyroid CarcinomaOncology, 2006
- The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)Proceedings of the National Academy of Sciences of the United States of America, 2005
- Molecular regulation of SREBP function: the Insig-SCAP connection and isoform-specific modulation of lipid synthesisBiochemistry and Cell Biology, 2004
- Liver X Receptor-dependent Repression of Matrix Metalloproteinase-9 Expression in MacrophagesJournal of Biological Chemistry, 2003
- Matrix metalloproteinases: they're not just for matrix anymore!Current Opinion in Cell Biology, 2001
- Interactions of the Low Density Lipoprotein Receptor Gene Family with Cytosolic Adaptor and Scaffold Proteins Suggest Diverse Biological Functions in Cellular Communication and Signal TransductionJournal of Biological Chemistry, 2000
- Cholesterol and the cell membraneBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1985